Institutional shares held 1.06 Million
0 calls
0 puts
Total value of holdings $2.37M
$0 calls
$0 puts
Market Cap $13.3M
5,951,000 Shares Out.
Institutional ownership 17.83%
# of Institutions 27


Latest Institutional Activity in LEXX

Top Purchases

Q3 2024
Geode Capital Management, LLC Shares Held: 150K ($335K)
Q3 2024
Vanguard Group Inc Shares Held: 109K ($243K)
Q3 2024
Bank Of Montreal Shares Held: 14K ($31.2K)
Q3 2024
High Tower Advisors, LLC Shares Held: 13K ($29K)
Q3 2024
Hrt Financial LP Shares Held: 10.3K ($22.9K)

Top Sells

Q3 2024
Invenomic Capital Management LP Shares Held: 476K ($1.06M)
Q3 2024
Raymond James Financial Services Advisors, Inc. Shares Held: 44.9K ($100K)
Q3 2024
Tower Research Capital LLC (Trc) Shares Held: 1.34K ($3K)
Q3 2024
Wells Fargo & Company Shares Held: 2.5K ($5.58K)
Q2 2024
Adar1 Capital Management, LLC Shares Held: 945 ($2.11K)

About LEXX

Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectively across the blood brain barrier. It operates a licensed in-house research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.


Insider Transactions at LEXX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
54.1K Shares
From 3 Insiders
Exercise of conversion of derivative security 2.5K shares
Open market or private purchase 51.6K shares
Sell / Disposition
2.57K Shares
From 1 Insiders
Open market or private sale 2.57K shares

Track Institutional and Insider Activities on LEXX

Follow Lexaria Bioscience Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LEXX shares.

Notify only if

Insider Trading

Get notified when an Lexaria Bioscience Corp. insider buys or sells LEXX shares.

Notify only if

News

Receive news related to Lexaria Bioscience Corp.

Track Activities on LEXX